Pasithea Therapeutics Corp. - KTTA

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Aug 14, 2026 SCHEDULE 13G/A Vivo Opportunity Fund Holdings, L.P. 9.99% 9,286,738 View
Aug 14, 2026 SCHEDULE 13G/A Vivo Opportunity, LLC 9.99% 9,286,738 View
Aug 14, 2026 SCHEDULE 13G/A Vivo Opportunity Cayman Fund, L.P. 9.99% 937,567 View
Aug 14, 2026 SCHEDULE 13G/A Vivo Opportunity Cayman, LLC 9.99% 937,567 View
Jul 31, 2026 SCHEDULE 13G/A Opaleye Management Inc. 6.14% 2,050,000 View
Jul 31, 2026 SCHEDULE 13G/A Opaleye, L.P. 6.14% 2,050,000 View
Jul 31, 2026 SCHEDULE 13G/A James Silverman 6.14% 2,050,000 View
Jul 01, 2026 SCHEDULE 13G/A Coastlands Capital LP 11.48% 3,835,035 View
Jul 01, 2026 SCHEDULE 13G/A Coastlands Capital Partners LP 11.48% 3,835,035 View
Jul 01, 2026 SCHEDULE 13G/A Coastlands Capital GP LLC 11.48% 3,835,035 View
Jul 01, 2026 SCHEDULE 13G/A Coastlands Capital LLC 11.48% 3,835,035 View
Jul 01, 2026 SCHEDULE 13G/A Matthew D. Perry 11.48% 3,835,035 View
Jun 23, 2026 SCHEDULE 13G Stonepine Capital Management, LLC 5.8% 1,952,550 View
Jun 23, 2026 SCHEDULE 13G Stonepine Capital, L.P. 5.8% 1,952,550 View
Jun 23, 2026 SCHEDULE 13G Stonepine GP, LLC 5.8% 1,952,550 View
Jun 23, 2026 SCHEDULE 13G Jon M. Plexico 5.8% 1,952,550 View
Apr 22, 2026 SCHEDULE 13G Funicular Funds, LP 7.4% 1,839,512 View
Apr 22, 2026 SCHEDULE 13G Cable Car Capital, LP 7.4% 1,839,512 View
Apr 22, 2026 SCHEDULE 13G Ma-Weaver Jacob 7.4% 1,839,512 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.